At P30, the CYP1A2 mRNA levels exhibited fold changes of 1.2 ± 0.3, 1.9 ± 0.7, 4.0 ± 1.4, and 1.9 ± 0.6 in the liver, BS, CLL, and COR, respectively, with respect to their levels at P7 (Table S2). Here, CYP1A2 is linked to B-cell chronic lymphocytic leukemia.